Assistant Professor, University of Pittsburgh
Neurosurgery
Dr. Andrew Ducruet, MD
|
|
Give Review
Andrew Ducruet, MD is an expert in the field of Neurosurgery. He went to Columbia University College of Physicians & Surgeons. Columbia University College of Physicians & Surgeons is a top medical university. Columbia University College of Physicians & Surgeons is ranked 8 in research and 52 in primary care medicine He received awards:"CMS Meaningful Use Stage 1 Certification". Andrew Ducruet is a published MD as well. He has 82 publications published. The latest was: Development of syndrome of inappropriate antidiuretic hormone secretion (SIADH) after Onyx embolisation of a cavernous carotid fistula. Doctor Andrew Ducruet, MD accepts Medicare payments and is listed with Medicare.gov.
Publications
- The Role of Matrix Metalloproteinase-9 in Subarachnoid Hemorrhage-Induced White Matter Injury.
- A rare marginal tentorial Artery to ophthalmic Artery anastomosis.
- The use of nanotechnology to improve the neuroprotective effects of adenosine in Stroke and spinal cord injury.
- Neurological morbidity and mortality associated with the endovascular treatment of cerebral Arteriovenous malformations before and during the Onyx era.
- Mammalian target of rapamycin (mTOR) activity promotes neuronal survival in Stroke with or without ischemic postconditioning.
- The Genetics of Aneurysms: A Complex Pathophysiology Requiring Complex Analysis.
- CEACAM1: A Novel Adhesion Molecule That Regulates the Secretion of Matrix Metalloproteinase-9 in Neutrophils and Protects the Blood-Brain Barrier After Ischemic Stroke.
- Resolution of cranial neuropathies following treatment of intracranial Aneurysms with the Pipeline Embolization Device.
- Preventing ischemia after Stroke: are pericytes the answer?
- Resveratrol and pharmacological potentiation in ischemic Stroke.
- Balloon remodeling of complex anterior communicating artery Aneurysms: technical considerations and complications.
- Methamphetamine use is an independent predictor of poor outcome after Aneurysmal subarachnoid hemorrhage.
- Endovascular advances for brain Arteriovenous malformations.
- Endovascular management of spinal Arteriovenous malformations.
- Reconstructive endovascular treatment of a ruptured vertebral artery dissecting Aneurysm using the Pipeline embolization device.
- Novel application of a balloon-anchoring technique for the realignment of a prolapsed Pipeline Embolization Device: a technical report.
- Multimodality Management of Vertebral Artery Injury Sustained During Cervical or Craniocervical Surgery.
- Regarding "Rate and Prognosis of Patients under Conscious Sedation Requiring Emergent Intubation during NeuroendoVascular Procedures"
- Long-term patency of venous sinus stents for idiopathic Intracranial hypertension.
- Transvenous to arterial Onyx embolization.
- The Evolution of Endovascular Treatment of Carotid Cavernous Fistulas: A Single-Center Experience.
- Transfemoral Transarterial Onyx Embolization of Carotid Body Paragangliomas: Technical Considerations, Results and Strategies for Complication Avoidance.
- Transvenous Coil Embolization of an Intraorbital Arteriovenous Fistula: Case Report and Review of the Literature.
- Technical considerations in the endovascular management of Aneurysms of the posterior inferior cerebellar artery.
- Balloon-Pump Counterpulsation for Management of Severe Cardiac Dysfunction After Aneurysmal Subarachnoid Hemorrhage.
- Gain-of-function polymorphisms of cystathionine β-synthase and delayed cerebral ischemia following Aneurysmal subarachnoid hemorrhage.
- A phase I clinical trial of tiopronin, a putative neuroprotective agent, in Aneurysmal subarachnoid hemorrhage.
- Genetic determinants of cerebral vasospasm, delayed cerebral ischemia, and outcome after Aneurysmal subarachnoid hemorrhage.
- Exacerbation of perihematomal edema and sterile meningitis with intraventricular administration of tissue plasminogen activator in patients with intraCerebral hemorrhage.
- Epidemiology of Aneurysmal subarachnoid hemorrhage.
- Preoperative antiepileptic drug administration and the incidence of postoperative seizures following bur hole-treated chronic subDural hematoma.
- The complement cascade as a therapeutic target in intraCerebral hemorrhage.
- Renal dysfunction as an independent predictor of outcome after Aneurysmal subarachnoid hemorrhage: a single-center cohort study.
- Intraoperative magnesium infusion during Carotid endarterectomy: a double-blind placebo-controlled trial.
- Response to open peer commentaries on "Bioethical considerations in translational research: primate Stroke".
- Bioethical considerations in translational research: primate Stroke.
- Endovascular occlusion of a ruptured transitional Aneurysm associated with a developmental venous anomaly. Case report.
- C3a receptor antagonist attenuates Brain injury after intracerebral hemorrhage.
- Complement inhibition as a proposed neuroprotective strategy following cardiac arrest.
- Impact of a protocol for acute antifibrinolytic therapy on Aneurysm rebleeding after subarachnoid hemorrhage.
- Protective effect of C5a receptor inhibition after murine reperfused Stroke.
- Deep hypothermic circulatory arrest for complex cerebral Aneurysms: lessons learned.
- C3a receptor modulation of granulocyte infiltration after murine focal Cerebral ischemia is reperfusion dependent.
- Pupillary reactivity upon hospital admission predicts long-term outcome in poor grade Aneurysmal subarachnoid hemorrhage patients.
- The role of complement in Stroke therapy.
- O-desulfated heparin improves outcome after rat Cerebral ischemia/reperfusion injury.
- Early plasma complement C3a levels correlate with functional outcome after Aneurysmal subarachnoid hemorrhage.
- Preclinical evaluation of the neuroprotective effect of soluble complement receptor type 1 in a nonhuman primate model of reperfused Stroke.
- A cerebroprotective dose of intravenous citrate/sorbitol-stabilized dehydroascorbic acid is correlated with increased Cerebral ascorbic acid and inhibited lipid peroxi...
- Complement component C3 mediates inflammatory injury following focal Cerebral ischemia.
- Temporal pattern of C1q deposition after transient focal Cerebral ischemia.
- Elevations in preoperative monocyte count predispose to acute neurocognitive decline after Carotid endarterectomy for asymptomatic Carotid artery stenosis.
- The complement system: a potential target for Stroke therapy.
- Galbraith Award: evaluation of risk factors associated with neurocognitive changes after Carotid endarterectomy.
- Intracranial pressure following Aneurysmal subarachnoid hemorrhage: monitoring practices and outcome data.
- Klippel-Trenaunay syndrome and cavernous Malformations.
- De novo glioblastoma in the territory of a prior middle cerebral Artery infarct.
- Interhemispheric Intracranial pressure gradients in nonhuman primate stroke.
- Elevation of monocyte chemoattractant protein-1 in patients experiencing neurocognitive decline following Carotid endarterectomy.
- Ortho-linked polyaryloxide ligands and their titanium complexes.
- Laser Doppler flowmetry in non-human primate Stroke studies: model refinement for pre-clinical development of cerebroprotective strategies.
- Pre-clinical evaluation of an sLe x-glycosylated complement inhibitory protein in a non-human primate model of reperfused Stroke.
- An improved functional neurological examination for use in nonhuman primate studies of focal reperfused Cerebral ischemia.
- Co-registration of radiographic and pathologic infarct territory in a non-human primate model of Stroke.
- A mouse model of intraCerebral hemorrhage using autologous blood infusion.
- Doppler ultrasonography screening of poor-grade subarachnoid hemorrhage patients increases the diagnosis of deep venous Thrombosis.
- Neuronal RAGE expression modulates severity of injury following transient focal Cerebral ischemia.
- Pharmacotherapy of Cerebral ischemia.
- The complement cascade: new avenues in Stroke therapy.
- Data presentation in rodent Stroke studies and the predictive value of confidence intervals.
- Intracranial infectious Aneurysms: a comprehensive review.
- Serial magnetic resonance imaging in experimental primate Stroke: validation of MRI for pre-clinical cerebroprotective trials.
- Polymorphisms in complement component 3 (C3F) and complement factor H (Y402H) increase the risk of postoperative neurocognitive dysfunction following Carotid endartere...
- Impact of platelet transfusion on hematoma expansion in patients receiving antiplatelet agents before intraCerebral hemorrhage.
- Evaluation of intraventricular hemorrhage assessment methods for predicting outcome following intraCerebral hemorrhage.
- Targeting lymphocytes in ischemic Stroke.
- Technological advances in the management of unruptured intracranial Aneurysms fail to improve outcome in New York state.
- Paradoxical exacerbation of neuronal injury in reperfused Stroke despite improved blood flow and reduced inflammation in early growth response-1 gene-deleted mice.
- Isoflurane preconditioning affords functional neuroprotection in a murine model of intraCerebral hemorrhage.
- Intranasal delivery of caspase-9 inhibitor reduces caspase-6-dependent axon/neuron loss and improves neurological function after Stroke.
- Development of syndrome of inappropriate antidiuretic hormone secretion (SIADH) after Onyx embolisation of a cavernous carotid Fistula.
Schools
Columbia Coll PhysampSurgNy Presbyterian Hosp
New York Presbyterian HospitalColumbia Presbyterian Center
BARROW NEUROLOGICAL INSTITUTE
Princeton U
Procedures Preformed
- Acute Stroke Intervention
- Aneurysm Embolization
- AVM Embolization
- Carotid Artery Stent Placement
- View All
Conditions Treated
- Aneurysm
- Arteriovenous Fistula
- Arteriovenous Malformation
- Arteriovenous Malformation (AVM) Brain
- View All
Doctors Specialties
- Endovascular Surgical Neuroradiology
- Neurosurgery
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Barrow Neurological Institute -
New York Presbyterian Hospital - Columbia Campus -
Columbia University College of Physicians & Surgeons
Hospital
-
UPMC Presbyterian Shadyside
Drug Facts
| NPI NUMBER | 1598924854 | |
| NPPES Provider LastName | DUCRUET | |
| NPPES Provider FirstName | ANDREW | |
| NPPES Provider ZIPCode | 152132536 | |
| NPPES Provider State | PA | |
| Specialty Description | Neurosurgery | |
| Total Claim Count | 16.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1598924854 |
| Last Name Of The Provider | DUCRUET |
| First Name Of The Provider | ANDREW |
| View All |
Similar Doctors
|
Dr. Ghassan K. Bejjani, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter E. Sheptak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alexander K. Yu, MD |
|
|
Dr. Alessandro Paluzzi, MD |
|
|
Dr. Brian T. Jankowitz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hideho Okada, MD
This Doctor is OpenDoctor Recommended.
|